Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
作者:Thomas Mendgen、Christian Steuer、Christian D. Klein
DOI:10.1021/jm201243p
日期:2012.1.26
campaigns, we decided to perform a systematic study on their promiscuity. An amount of 163 rhodanines, hydantoins, thiohydantoins, and thiazolidinediones were synthesized and tested against several targets. The compounds were also characterized with respect to aggregation and electrophilic reactivity, and the binding modes of rhodanines and relatedcompounds in published X-ray cocrystal structures were analyzed
Imidazo[2,1-b]thiazepines: synthesis, structure and evaluation of benzodiazepine receptor binding
作者:Katarzyna Kieć-Kononowicz、Janina Karolak-Wojciechowska、Barbara Michalak、Elżbieta Pękala、Britta Schumacher、Christa E Müller
DOI:10.1016/j.ejmech.2003.11.009
日期:2004.3
of our search for new ligands acting on benzodiazepinereceptors among the fused 2-thiohydantoin derivatives, a series of 5-substituted imidazo[2,1-b]thiazepines was synthesized and investigated in radioligand binding studies at the benzodiazepinebinding site of GABA(A) receptors in rat brain cortical membranes. Among ortho-substituted 5-arylidene-imidazo[2,1-b]thiazepines compounds could be identified
presence of ascorbic acid and ferric ions. Superoxide anions (02− anionradicals) were generated enzymatically in the xanthine‐xanthine oxidase system. Among the 20 investigated compounds only four fused arylidene 2‐thiohydantoin derivatives showed weak antioxidant activity scavenging OH radicals. There is a relationship between the electrophilic OH radical scavenging properties (RSC) of the tested molecules
Arylmethylenyl derivatives of thiazolidnones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflamatory agents
申请人:WARNER-LAMBERT COMPANY
公开号:EP0343643A2
公开(公告)日:1989-11-29
The present invention is for selected novel compounds, as well as, pharmaceutical compositions and methods of use for known and the selected novel compounds both of the formula
having activity useful for treating allergies and inflammation.
Known and selected novel arylmethylenyl derivatives of imidazolidinones useful as antiallergy agents and antiinflammatory agents
申请人:WARNER-LAMBERT COMPANY
公开号:EP0565135A1
公开(公告)日:1993-10-13
The present invention is for selected novel compounds, as well as, pharmaceutical compositions and methods of use for known and the selected novel compounds both of the formula
having activity useful for treating allergies and inflammation.